Annual Meeting

Computation is the new experiment

A Discover BMB symposium: Artificial Intelligence and Machine Learning in Structural Biology, Drug Design and Systems Biology
Rommie E. Amaro Celia Schiffer
By Rommie E. Amaro and Celia Schiffer
Sept. 20, 2022

After decades of playing second fiddle, computation is now taking center stage — achieving critical insights that experimentation alone cannot provide. We are witnessing a dramatic rise in artificial intelligence–based methods coupled with year-on-year improvements of physics-based approaches. We now can fold a protein accurately from sequence alone!

Game-changing methods in protein and enzyme design are hurtling toward us. Scientists now can integrate numerous experimental data sets into computational models to explore previously unseen elements at (and across) scales never before achieved. Computational simulations are rewriting textbooks — from molecules to system dynamics and function. Machine learning is transforming drug design and development.

All in all, you will not find a symposium at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, filled with more excitement and possibility than ours. Buckle up for a thrilling ride in March in Seattle!

Keywords: Artificial intelligence, structural biology, simulation, drug discovery, bioinformatics, systems biology, machine learning.

Who should attend: All who want to find out how computation is transforming biological problem-solving.

Theme song: “Respect” by Aretha Franklin, because computation deserves it.

This session is powered by a powerful flux capacitor.

Speakers

Structure determination
Debora MarksHarvard Medical School
Rommie E. Amaro (chair), University of California, San Diego
Ramanathan ArvindArgonne National Laboratory; University of Chicago
Jason PerryGilead Sciences Inc.

Drug design
John ChoderaSloan Kettering Institute
David BakerUniversity of Washington
Steve CapuzziVertex Pharmaceuticals
Celia Schiffer (chair), University of Massachusetts Chan Medical School

Bioinformatics / Systems biology
Marian WalhoutUniversity of Massachusetts Chan Medical School
Janet GeorgeIntel Corporation
Ivet Bahar (chair), University of Pittsburgh School of Medicine
Henry van dem BedamAtomWise Inc.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Rommie E. Amaro
Rommie E. Amaro

Rommie E. Amaro is a professor in the chemistry and biochemistry department at the University of California, San Diego.

Celia Schiffer
Celia Schiffer

Celia A. Schiffer is chair of the University of Massachusetts Chan Medical School Department of Biochemistry and Molecular Biotechnology.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Journal News

How antigen-processing proteins shape immunity

Nov. 6, 2025

Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.

New chemical strategy boosts accuracy in proteomics
Journal News

New chemical strategy boosts accuracy in proteomics

Nov. 6, 2025

Researchers develop a methylamine-based method that nearly eliminates peptide overlabeling in proteomics, improving accuracy in protein identification and quantitation.

Understanding the roles of extracellular matrix and vesicles in valvular disease
Profile

Understanding the roles of extracellular matrix and vesicles in valvular disease

Oct. 30, 2025

MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Journal News

Lipid profiles reveal sex differences in type 2 diabetes

Oct. 29, 2025

Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Journal News

Serum lipids may predict early diabetes risk

Oct. 29, 2025

Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.